Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Overview of attention for article published in The Lancet Haematology, December 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 15 X users
reddit: 2 Redditors
guideline: 5 clinical guideline sources

Readers on

mendeley: 126 Mendeley

So far, Altmetric has seen 18 X posts from 15 X users, with an upper bound of 55,219 followers.

RT @crabb_vicki: @JT4TheReturn @FrankDElia7 @ReneeBa41879905 @SkepticalMutant @ToBornin @TheFrankmanMN @JCDeardeuff @iXeno @cappsie @handma…

@JT4TheReturn @FrankDElia7 @ReneeBa41879905 @SkepticalMutant @ToBornin @TheFrankmanMN @JCDeardeuff @iXeno @cappsie @handmadekathy @IainMulady @doritmi @TruthTwt @Izzitreally2 @Jccalmond2 @Monstercoyliar @krebiozen @TweetOfSteiner @Augusti03401363 @ianfmus…

@HerHalo3 @lindsaylohanxox @The_Seeadler @DeannaMariaR1 @alisonpalk @John22051340 @tripl3zer0_ @tnicholsmd @momanoms2 @unhealthytruth Oral Dabigatran was studied w/ data submitted prior to the pandemic. Prior to that, children had to receive daily inj…

@_LiveGrateful @HenryMullen500 @DwjamP @TheNo1Waffler https://t.co/vqsE1abM1C this trial started in 2014. So not exactly interesting.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 14 additional X posts.